Ajanta Pharma develops and commercializes diverse range of innovative generic products. Our research centre has built strong capabilities for developing generic formulations and process chemistry. We are amongst the front runners in the segments of Cardiovascular, dermatology and ophthalmology in India. Many of our brands hold leading positions in their respective sub-therapeutic classes. A clear therapeutic focus has lead to create a strong product portfolio for us.

We also have a significant global presence in the Male Erectile Dysfunction (MED) segment through our key brand ‘Kamagra’ and equally strong equity in Anti-malarial segment through ‘Artefan’ where we are the first branded generic to get WHO pre-qualified.